Eylea (aflibercept ophthalmic) Drug Interactions
There are no known drug interactions for Eylea (aflibercept ophthalmic) - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Eylea (aflibercept ophthalmic) is in the drug class anti-angiogenic ophthalmic agents. Eylea (aflibercept ophthalmic) is used to treat the following conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Edema.
Eylea (aflibercept ophthalmic) disease Interactions
There is 1 disease interaction with Eylea (aflibercept ophthalmic):
More about Eylea (aflibercept ophthalmic)
- Eylea Side Effects
- During Pregnancy
- Dosage Information
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 14 Reviews
- Drug class: anti-angiogenic ophthalmic agents
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.